Figure 2.
Antiproliferative activity of compounds on cancer and normal cells. (A, B) BEAS-2B, A549, and H1795 cells were subjected to treatment with compounds 38 and 45 at various concentrations for 72 h. Cell viability was assessed using an MTT assay. (C, D) BEAS-2B, A549, and H1795 cells were subjected to treatment with doxorubicin and paclitaxel at various concentrations for 72 h. Cell viability was assessed using the MTT assay. n = 3.
